adenosine has been researched along with Hepatitis B Virus Infection in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baba, M; Ikeda, M; Moriishi, K; Muramatsu, M; Okamoto, M; Sharon, A; Toyama, M; Wakita, T; Watashi, K; Yamashita, A | 1 |
| Gao, W; Huang, H; Jin, L; Lin, J; Qu, S; Zeng, Z | 1 |
| Chu, CK; Konreddy, AK; Rawal, RK | 1 |
| Chayama, K; Takahashi, S | 1 |
1 review(s) available for adenosine and Hepatitis B Virus Infection
| Article | Year |
|---|---|
[Attention-getting sexually transmitted diseases: Hepatitis B].
Topics: Adenine; Adenosine; Antiviral Agents; Comorbidity; Drug Therapy, Combination; Genotype; Guanine; Guanosine; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Organophosphonates; Reverse Transcriptase Inhibitors; Sexually Transmitted Diseases, Viral | 2007 |
3 other study(ies) available for adenosine and Hepatitis B Virus Infection
| Article | Year |
|---|---|
Novel Neplanocin A Derivatives as Selective Inhibitors of Hepatitis B Virus with a Unique Mechanism of Action.
Topics: Adenosine; Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; RNA; Virus Replication | 2022 |
A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis.
Topics: Adenosine; AlkB Homolog 5, RNA Demethylase; Animals; Carcinogenesis; Carcinoma, Hepatocellular; Case-Control Studies; Feedback, Physiological; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Histones; Humans; Intracellular Signaling Peptides and Proteins; Liver; Liver Neoplasms; Male; Mice; Middle Aged; Prognosis; Promoter Regions, Genetic; RNA-Seq; Trans-Activators; Viral Regulatory and Accessory Proteins; Xenograft Model Antitumor Assays | 2021 |
Mechanism of Adefovir, Tenofovir and Entecavir Resistance: Molecular Modeling Studies of How A Novel Anti-HBV Agent (FMCA) Can Overcome the Drug Resistance.
Topics: Adenine; Adenosine; Amino Acid Sequence; Antiviral Agents; Binding Sites; Catalytic Domain; Databases, Protein; Drug Resistance, Viral; Gene Products, pol; Guanine; Hepatitis B; Hepatitis B virus; HIV Reverse Transcriptase; Humans; Hydrogen Bonding; Molecular Dynamics Simulation; Molecular Sequence Data; Mutation; Organophosphonates; Sequence Alignment; Tenofovir | 2015 |